Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1992-3-30
pubmed:abstractText
The SCL gene, initially discovered at the site of a translocation breakpoint associated with the development of a stem cell leukemia, encodes a protein that contains the highly conserved basic helix-loop-helix (bHLH) motif found in a large array of eukaryotic transcription factors. Recently, we have described a nonrandom, site-specific SCL rearrangement in several T-cell acute lymphoblastic leukemia (ALL) cell lines that juxtaposes SCL with a distinct transcribed locus, SIL. The SIL/SCL rearrangement was found in leukemic blasts from 11 of 70 (16%) newly diagnosed T-cell ALL patients, a prevalence substantially higher than that of the t(11;14) translocation, which has previously been reported as the most frequent nonrandom chromosomal abnormality in T-cell ALL. We did not detect the SIL/SCL rearrangement in the leukemic blasts from 30 patients with B-cell precursor ALL, indicating that the rearrangement was specific for T-cell ALL. Analysis of RNA from these patients indicated that an SIL/SCL fusion mRNA was formed, joining SIL and SCL in a head-to-tail fashion. The fusion occurs in the 5' untranslated region (UTR) of both genes, preserving the SCL coding region. The net result of this rearrangement is that SCL mRNA expression becomes regulated by the SIL promoter, leading to inappropriate SCL expression. The resultant inappropriate expression of this putative transcription factor may then contribute to leukemic transformation in T-cell ALL.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
79
pubmed:geneSymbol
LYL1, SCL
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1327-33
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:1311214-Alleles, pubmed-meshheading:1311214-Base Sequence, pubmed-meshheading:1311214-Basic Helix-Loop-Helix Transcription Factors, pubmed-meshheading:1311214-Blotting, Southern, pubmed-meshheading:1311214-Child, pubmed-meshheading:1311214-DNA, Neoplasm, pubmed-meshheading:1311214-DNA-Binding Proteins, pubmed-meshheading:1311214-Gene Expression Regulation, Neoplastic, pubmed-meshheading:1311214-Gene Rearrangement, pubmed-meshheading:1311214-Gene Rearrangement, delta-Chain T-Cell Antigen Receptor, pubmed-meshheading:1311214-Humans, pubmed-meshheading:1311214-Immunophenotyping, pubmed-meshheading:1311214-Leukemia-Lymphoma, Adult T-Cell, pubmed-meshheading:1311214-Molecular Sequence Data, pubmed-meshheading:1311214-Promoter Regions, Genetic, pubmed-meshheading:1311214-Proto-Oncogene Proteins, pubmed-meshheading:1311214-RNA, Messenger, pubmed-meshheading:1311214-Transcription Factors, pubmed-meshheading:1311214-Translocation, Genetic
pubmed:year
1992
pubmed:articleTitle
Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.
pubmed:affiliation
National Cancer Institute/Navy Medical Oncology Branch, National Naval Medical Center, Bethesda, MD 20889.
pubmed:publicationType
Journal Article